402 related articles for article (PubMed ID: 18292504)
1. Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance.
Selvaraj RK; Geiger TL
J Immunol; 2008 Mar; 180(5):2830-8. PubMed ID: 18292504
[TBL] [Abstract][Full Text] [Related]
2. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.
Carrier Y; Yuan J; Kuchroo VK; Weiner HL
J Immunol; 2007 Jan; 178(1):179-85. PubMed ID: 17182553
[TBL] [Abstract][Full Text] [Related]
3. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen.
Yu P; Gregg RK; Bell JJ; Ellis JS; Divekar R; Lee HH; Jain R; Waldner H; Hardaway JC; Collins M; Kuchroo VK; Zaghouani H
J Immunol; 2005 Jun; 174(11):6772-80. PubMed ID: 15905518
[TBL] [Abstract][Full Text] [Related]
4. IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.
Wang D; Ghosh D; Islam SM; Moorman CD; Thomason AE; Wilkinson DS; Mannie MD
J Immunol; 2016 Oct; 197(8):2992-3007. PubMed ID: 27619998
[TBL] [Abstract][Full Text] [Related]
5. Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells.
Rynda-Apple A; Huarte E; Maddaloni M; Callis G; Skyberg JA; Pascual DW
Eur J Immunol; 2011 Feb; 41(2):313-23. PubMed ID: 21268002
[TBL] [Abstract][Full Text] [Related]
6. Autoreactive T cells persist in rats protected against experimental autoimmune encephalomyelitis and can be activated through stimulation of innate immunity.
Conant SB; Swanborg RH
J Immunol; 2004 May; 172(9):5322-8. PubMed ID: 15100271
[TBL] [Abstract][Full Text] [Related]
7. Regulation of polyclonal T cell responses by an MHC anchor-substituted variant of myelin oligodendrocyte glycoprotein 35-55.
Ford ML; Evavold BD
J Immunol; 2003 Aug; 171(3):1247-54. PubMed ID: 12874212
[TBL] [Abstract][Full Text] [Related]
8. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
[TBL] [Abstract][Full Text] [Related]
9. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
Sun JB; Czerkinsky C; Holmgren J
J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
[TBL] [Abstract][Full Text] [Related]
10. Novel CD8+ Treg suppress EAE by TGF-beta- and IFN-gamma-dependent mechanisms.
Chen ML; Yan BS; Kozoriz D; Weiner HL
Eur J Immunol; 2009 Dec; 39(12):3423-35. PubMed ID: 19768696
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b
Arellano G; Acuña E; Loda E; Moore L; Tichauer JE; Castillo C; Vergara F; Burgos PI; Penaloza-MacMaster P; Miller SD; Naves R
J Neuroinflammation; 2024 May; 21(1):144. PubMed ID: 38822334
[TBL] [Abstract][Full Text] [Related]
12. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
13. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis.
Matsushita T; Horikawa M; Iwata Y; Tedder TF
J Immunol; 2010 Aug; 185(4):2240-52. PubMed ID: 20624940
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.
Chen SJ; Wang YL; Lo WT; Wu CC; Hsieh CW; Huang CF; Lan YH; Wang CC; Chang DM; Sytwu HK
Clin Exp Immunol; 2010 Nov; 162(2):210-23. PubMed ID: 21069936
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis.
Zhang H; Podojil JR; Chang J; Luo X; Miller SD
J Immunol; 2010 Jun; 184(12):6629-36. PubMed ID: 20483764
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis.
Kohm AP; Carpentier PA; Anger HA; Miller SD
J Immunol; 2002 Nov; 169(9):4712-6. PubMed ID: 12391178
[TBL] [Abstract][Full Text] [Related]
17. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.
Komiyama Y; Nakae S; Matsuki T; Nambu A; Ishigame H; Kakuta S; Sudo K; Iwakura Y
J Immunol; 2006 Jul; 177(1):566-73. PubMed ID: 16785554
[TBL] [Abstract][Full Text] [Related]
18. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.
Hirata S; Senju S; Matsuyoshi H; Fukuma D; Uemura Y; Nishimura Y
J Immunol; 2005 Feb; 174(4):1888-97. PubMed ID: 15699115
[TBL] [Abstract][Full Text] [Related]
19. Myelin-reactive, TGF-β-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo.
O'Connor RA; Leech MD; Suffner J; Hämmerling GJ; Anderton SM
J Immunol; 2010 Dec; 185(12):7235-43. PubMed ID: 21084662
[TBL] [Abstract][Full Text] [Related]
20. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG
J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
